This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Albert Brennauer: Innovator in Receptor Agonists
Introduction
Albert Brennauer is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of receptor agonists. His work is instrumental in advancing therapeutic options for various medical conditions.
Latest Patents
Albert Brennauer holds a patent for "NPY2 Receptor Agonists." This innovation is crucial for understanding and manipulating neuropeptide Y receptors, which play a vital role in numerous physiological processes.
Career Highlights
Brennauer is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company has allowed him to focus on groundbreaking research and development in the pharmaceutical sector.
Collaborations
He has collaborated with esteemed colleagues such as Soren Ljungberg Pedersen and Stefan Peters. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Albert Brennauer's contributions to receptor agonists exemplify the impact of dedicated inventors in the pharmaceutical industry. His work continues to influence advancements in medical science and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile